Journal
HAEMATOLOGICA
Volume 100, Issue 11, Pages E450-E453Publisher
FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2015.132837
Keywords
JAK mutations; CTCL; ruxolitinib; JAK/STAT; targeted therapy; molecular diagnostics
Categories
Ask authors/readers for more resources
Share Paper
